The relationship between the number of available therapeutic options and government payer (medicare part D) spending on topical drug products

Michael C. Kwa, Kyle Tegtmeyer, Leah J. Welty, Sam G. Raney, Markham C. Luke, Shuai Xu*, Betty Kong

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'The relationship between the number of available therapeutic options and government payer (medicare part D) spending on topical drug products'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science